Full-Time

Service Education Instructional Designer

Image Guided Therapy Devices

Posted on 12/2/2025

Philips

Philips

Manufactures sleep therapy and respiratory devices

Compensation Overview

$105k - $137k/yr

+ Annual Incentive Bonus + Long-Term Incentives

No H1B Sponsorship

Mayfield Heights, OH, USA + 3 more

More locations: Wayzata, MN, USA | Colorado Springs, CO, USA | San Diego, CA, USA

In Person

Office-based role; in-person presence required; minimum 3 days/week in the office.

US Citizenship Required

Category
Education
Requirements
  • You have a bachelor’s degree in medical device education, ideally Instructional Design, or related field.
  • You have acquired 2+ years’ experience in the instructional design domain with hands-on experience building learning programs.
  • Your skills include adult learning methodologies (including ADDIE), a variety of tested learning theories and experience with a Learning Management System (LMS). Confident use of learning development tools (MS Office Suite, Articulate Storyline 360, etc.).
  • You are comfortable working in a metrics-driven environment; capable of turning data into insights and actions to improve team and learner outcomes.
  • Excellent verbal and written communication skills
  • Excellent interpersonal communication skills, as well as being a motivated, collaborative team player.
  • Ability to be occasionally flexible with working hours to accommodate meetings with alternate time zones.
  • You must be able to successfully perform the following minimum Physical, Cognitive and Environmental job requirements with or without accommodation.
  • Willingness to travel if/when business requires (<20%).
  • You must reside in or within commuting distance to Highland Heights OH; Colorado Springs CO, Plymouth MN or San Diego CA.
Responsibilities
  • Act as a trusted advisor in the area of innovative education delivery methods and techniques, while ensuring relevant quality, legal, and compliance requirements are met.
  • Cooperatively work with subject matter experts to design engaging learning activities using a macro- and micro-view of the learning journey, with a strong focus on remote and distance learning.
  • Work in a team to maintain our Course Development Process, guide development through the process, participate in audits, and work to resolve any resulting CAPAs.
  • Gather and document requirements for learning products and identify materials such as quick step guides, learning services checklists, delivery specialist/instructor guides.
  • Outline course and/or modular content and participate in storyboarding and the creation of education content.
  • Create consistent, streamlined learning services using common company style, standards and development tools and design, c and populate course materials in the Learning Management System (LMS) and perform tests to make sure it is functional.
  • Draw upon a working knowledge of integrating multi-media, advanced simulations, and other learning activities to effectively teach concepts and technical/clinical skills supported by a documented instructional design.
  • Report on team performance and project impact using defined KPIs and data from the LMS, learner feedback, and other analytics tools.
Desired Qualifications
  • None

Philips Respironics designs sleep and respiratory care devices, including CPAP and BiPAP machines, ventilators, and oxygen concentrators, plus related systems. These devices deliver regulated air pressure, support or assist breathing, and provide concentrated oxygen, often paired with software and data tools for monitoring. The division differentiates itself through its long history within Philips and its integrated ecosystem that connects devices with analytics and clinical support across hospital, clinic, and home settings. Its goal is to improve quality of life and clinical outcomes for people with sleep and respiratory conditions by offering reliable devices, patient support, and data-driven care.

Company Size

N/A

Company Stage

Acquired

Total Funding

$5.1B

Headquarters

Murrysville, Pennsylvania

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • BioTelemetry acquisition in 2020 expands remote heart monitoring.
  • $479 million settlement in September 2023 closes US litigation.
  • New silicone foam validated safe, enabling global device sales.

What critics are saying

  • ResMed seizes US sleep market share within 6-12 months.
  • FDA consent decree blocks US sales until after 2026.
  • January 2024 US ventilation exit halves revenue permanently.

What makes Philips unique

  • Pioneered CPAP therapy as standard for sleep apnea since 1976.
  • Leads in non-invasive ventilation and home respiratory support.
  • Integrates devices with software for data-driven clinical outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Health Savings Account/Flexible Spending Account

Company News

HIT Consultant
Apr 12th, 2024
Philips Respironics Reaches Final Agreement With Us Regulators On Sleep Apnea Device Recall

<img src="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp" alt="Philips Respironics Reaches Final Agreement with US Regulators on Sleep Apnea Device Recall. " class="wp-image-78777" srcset="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp 700w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-300x161.webp 300w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-290x155.webp 290w" sizes="(max-width: 700px) 100vw, 700px">What You Should Know: – Philips Respironics, a subsidiary of Royal Philips, has finalized a consent decree with the US Department of Justice (DOJ) and Food and Drug Administration (FDA) to address issues raised during a 2021 inspection of a Philips facility in Pennsylvania.– The agreement focuses on Philips Respironics’ operations in the US, particularly regarding the recall of certain sleep and respiratory care devices.– The company’s focus will now be on completing remediation efforts, ensuring patient safety, and regaining regulatory approval to resume sales of new devices in the US.Focus on Remediation and ComplianceThe consent decree outlines a roadmap for Philips Respironics to:Prioritize Recall Remediation: Philips will continue efforts to remediate millions of sleep apnea and respiratory care devices recalled in June 2021 due to potential health risks associated with degraded sound abatement foam.Independent Oversight: Independent experts will be brought in to review recall remediation efforts and ensure Philips Respironics’ business operations comply with FDA regulations.Continued Patient Support: Philips Respironics can continue servicing existing devices in the hands of patients and healthcare providers. Additionally, they can sell accessories, consumables, and replacement parts for these devices.Sales Restrictions Remain in USThe FDA has not yet authorized Philips Respironics to resume sales of new CPAP, BiPAP, or other respiratory care devices in the US. This restriction will remain in place until Philips meets the requirements outlined in the consent decree.Global Sales Continue with RestrictionsPhilips Respironics can continue to sell new devices, accessories, consumables, and replacement parts outside the US,  subject to specific requirements.Safety of Devices with New Foam ConfirmedPhilips Respironics has conducted tests on devices using a new silicone sound abatement foam and found no safety issues. Patients can continue to use these devices following the instructions for use.Financial ImpactPhilips anticipates incurring costs associated with remediation activities and profit disgorgement related to US sales. These costs are estimated at 100 basis points in 2024.  The company’s previously announced 2023-2025 financial outlook remains unchanged,  already factoring in the consent decree. “Strengthening patient safety and quality remains Philips’ highest priority and the increased scrutiny will help us to improve even more

Goodrich Pharmacy
Jan 29th, 2024
Phillips Suspends U.S. Sales of CPAP, Ventilator Machines After Recall

Following a recall of millions of its breathing machines that began in mid-2021, Phillips Respironics announced Monday that it would halt sales of all such machines within the United States.

Parker Waichman LLP
Mar 23rd, 2023
Sleep Apnea Patients Suffer While Waiting To Receive Their Repaired Philips CPAP Machines

In June of 2021, Philips began a recall of over five million of its breathing devices due to toxic fume and substances emanating from the devices’ sound abatement foam.

Digital Journal
Jan 13th, 2023
Ultrasound Market Share | Market | Report | Analysis 2032 | Key Players: Fujifilm Holdings Corporation, Analogic Corporation, Siemens Healthcare among others

February 2019 – Koninklijke Philips launched the EPIQ Elite ultrasound system in the market.

VentureBeat
Oct 26th, 2022
Philips Norelco Brings Movember To Roblox With Shavetopia

Register now for your free virtual pass to the Low-Code/No-Code Summit this November 9. Hear from executives from Service Now, Credit Karma, Stitch Fix, Appian, and more. Learn more. Philips Norelco is creating an interactive metaverse experience called Shavetopia in Roblox, based around the Movember trend. For anyone who doesn’t know what that is, Movember is where people grow facial hair for the entire month of November. The portmanteau comes from adding the word mustache to the name of the month

INACTIVE